CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
CYTOSORBENTS CORPORATION (CTSO) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $0.95 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.95.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.90.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $1.03.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $1.63.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $0.95 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $0.90 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.03 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.63 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.24 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.10 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.09 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.08 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.99 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.64 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.89 10-K · filed 2026-03-30 | |
| 2023-09-30 | $1.88 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.61 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $2.00 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $1.84 10-K · filed 2025-03-31 | $2.10 10-K · filed 2023-03-09 |
| 2022-09-30 | $2.13 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.11 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $4.30 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $4.68 10-K · filed 2023-03-09 | |
| 2021-09-30 | $4.55 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $4.55 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $4.10 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $4.12 10-K · filed 2022-03-10 | |
| 2020-09-30 | $4.00 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $4.03 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $4.03 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $4.49 10-K · filed 2021-03-09 | |
| 2019-09-30 | $4.58 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $4.70 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $4.65 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $4.56 10-K · filed 2020-03-05 | |
| 2018-09-30 | $4.52 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $4.38 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $4.12 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $3.31 10-K · filed 2019-03-07 | $0.70 10-K · filed 2018-03-08 |
| 2017-09-30 | $0.62 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $0.68 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $0.49 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $2.55 10-K · filed 2018-03-08 | |
| 2016-09-30 | $2.54 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.52 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.89 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.72 10-K · filed 2017-03-03 | |
| 2015-09-30 | $2.36 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $2.22 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $0.07 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.37 10-K · filed 2016-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |